StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Outside U.S. revenue growth YoY by Quarter

Outside U.S. revenue growth YoY (%) (%)

QuarterlyAnnual

Eli Lilly Outside U.S. revenue growth YoY: 80.0% in Q2 2026, up 43.0 pts from a year earlier.

Latest, Q2 2026
80.0%
Period ended Jun 30, 2026
Change on a year earlier
+43.0 pts
37.0% in Q2 2025
History
32 quarters
Since Q1 2018
Sources
32
Documents cited below

Where the Q2 2026 figure comes from

“|| Percent change | 33 | % | 80 | % | 48 | % | 37 | % | 81 | % | 51 | %”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A Revenue Growth Decomposition Table & Form 8-K Q4 Releases.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOutside U.S. revenue growth YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 202680.0%+43.0 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202681.0%+43.0 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q4 2025Dec 31, 202543.0%-12.0 ptsEarnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 202574.0%+86.0 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 202537.0%+12.0 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 202538.0%+16.0 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202455.0%+45.0 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 2024-12.0%-76.0 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 202425.0%+16.0 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 202422.0%+26.0 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 202310.0%+16.0 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202364.0%+73.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 20239.0%+25.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 2023-4.0%+4.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022-6.0%-5.0 ptsEarnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 2022-9.0%-17.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗

Breakdown

What makes up outside U.S. revenue growth YoY

Cite this data

StockData. (2026). Eli Lilly Outside U.S. revenue growth YoY (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-nonus-total

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.